The role of noncoding RNAs in metabolic reprogramming of cancer cells

被引:10
|
作者
Safi, Amir [1 ]
Saberiyan, Mohammadreza [2 ]
Sanaei, Mohammad-Javad [3 ]
Adelian, Samaneh [2 ]
Asl, Fateme Davarani [2 ]
Zeinaly, Mahsa [4 ]
Shamsi, Mahdi [5 ]
Ahmadi, Reza [6 ]
机构
[1] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Clin Biochem Res Ctr, Shahrekord, Iran
[2] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Cellular & Mol Res Ctr, Shahrekord, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Hematol & Blood Banking, Tehran, Iran
[4] Univ Guilan, Fac Sci, Dept Biol, Rasht, Iran
[5] Islamic Azad Univ, Dept Cell & Mol Biol, Najafabad Branch, Najafabad, Iran
[6] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Med Plants Res Ctr, Shahrekord, Rahmatiyeh, Iran
关键词
Cancer; Metabolic reprogramming; Noncoding RNAs; MicroRNA; Long noncoding RNA; Circular RNA; REGULATES GLUCOSE-METABOLISM; TARGETING HEXOKINASE 2; LUNG-CANCER; LIPID-METABOLISM; PROMOTES GLYCOLYSIS; TUMOR PROGRESSION; LIVER-CANCER; HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; C-MYC;
D O I
10.1186/s11658-023-00447-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reprogramming is a well-known feature of cancer that allows malignant cells to alter metabolic reactions and nutrient uptake, thereby promoting tumor growth and spread. It has been discovered that noncoding RNAs (ncRNAs), including microRNA (miRNA), long noncoding RNA (lncRNA), and circular RNA (circRNA), have a role in a variety of biological functions, control physiologic and developmental processes, and even influence disease. They have been recognized in numerous cancer types as tumor suppressors and oncogenic agents. The role of ncRNAs in the metabolic reprogramming of cancer cells has recently been noticed. We examine this subject, with an emphasis on the metabolism of glucose, lipids, and amino acids, and highlight the therapeutic use of targeting ncRNAs in cancer treatment.
引用
下载
收藏
页数:31
相关论文
共 50 条
  • [21] Death by Lipids: role of noncoding RNAs in metabolic stress
    Schaffer, Jean
    FASEB JOURNAL, 2020, 34
  • [22] Death by Lipids: role of noncoding RNAs in metabolic stress
    Schaffer, Jean
    FASEB JOURNAL, 2021, 35
  • [23] The regulatory role of long noncoding RNAs in cancer
    Tang, Ying
    Cheung, Belamy B.
    Atmadibrata, Bernard
    Marshall, Glenn M.
    Dinger, Marcel E.
    Liu, Pei Y.
    Liu, Tao
    CANCER LETTERS, 2017, 391 : 12 - 19
  • [24] Ferroptosis in Cancer Progression: Role of Noncoding RNAs
    Zuo, Ying-Bing
    Zhang, Yin-Feng
    Zhang, Rui
    Tian, Jia-Wei
    Lv, Xiao-Bing
    Li, Rong
    Li, Shu-Ping
    Cheng, Meng-Die
    Shan, Jing
    Zhao, Zheng
    Xin, Hui
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (05): : 1829 - 1843
  • [25] The role of noncoding RNAs in cancer lipid metabolism
    Wang, Ye
    Li, Qian
    Wang, Song
    Wang, Bi-jun
    Jin, Yan
    Hu, Hao
    Fu, Qing-sheng
    Wang, Jia-wei
    Wu, Qing
    Qian, Long
    Cao, Ting-ting
    Xia, Ya-bin
    Huang, Xiao-xu
    Xu, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Noncoding RNAs in Growth and Death of Cancer Cells
    Liu, Anfei
    Liu, Shanrong
    LONG AND SHORT NONCODING RNAS IN CANCER BIOLOGY, 2016, 927 : 137 - 172
  • [27] The role of long noncoding RNAs in epithelial to mesenchymal transition and cancer stem cells
    Herschkowitz, Jason I.
    Coarfa, Cristian
    Prat, Aleix
    Toneff, Michael J.
    Hoadley, Katherine A.
    Dinger, Marcel E.
    Mattick, John S.
    Mani, Sendurai A.
    Perou, Charles M.
    Rosen, Jeffrey M.
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [28] Research for Reprogramming of Cancer Cells by Micro RNAs
    Miyazaki, S.
    Yamamoto, H.
    Haraguchi, N.
    Nishimura, J.
    Hata, T.
    Takemasa, I.
    Mizushima, T.
    Ishii, H.
    Doki, Y.
    Mori, M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S75 - S75
  • [29] Emerging role of non-coding RNAs in glucose metabolic reprogramming and chemoresistance in colorectal cancer
    Yan, Shushan
    Wang, Shufeng
    Wang, Xinyi
    Dai, Wenqing
    Chu, Jinjin
    Cheng, Min
    Guo, Zhiliang
    Xu, Donghua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] The role of metabolic reprogramming in kidney cancer
    Chen, Ziyi
    Zhang, Xiaohong
    FRONTIERS IN ONCOLOGY, 2024, 14